Insider · CIK 0001553593
Michael W. Dunne
Files at ITRM (Iterum Therapeutics plc). First filing Nov 27, 2023, latest Nov 20, 2025.
In brief
Michael W. Dunne files SEC Form 4 as director at ITRM (Iterum Therapeutics plc). Since Nov 27, 2023, Michael W. Dunne has reported 5 open-market buys worth $107k and 0 open-market sells worth $0, the latest filed on Nov 20, 2025.
A track record needs three past buys with six months of prices behind them; Michael W. Dunne has 0, so none is measured yet.
The newest scored trade: bought $2,191 of ITRM on Nov 18, 2025, filed Nov 20, 2025, scored 15 (weak). In the last 12 months: 1 buy worth $2,191 and 0 sells worth $0.
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | ITRMbuy Iterum Therapeutics plc | $2,191 6,000 shares | +3% | - | |
| 18Weak | ITRMbuy Iterum Therapeutics plc | $11k 15,000 shares | +7% | - | |
| 32Weak | ITRMbuy Iterum Therapeutics plc | $35k 25,000 shares | +28% | - | |
| 23Weak | ITRMbuy Iterum Therapeutics plc | $18k 10,000 shares | +13% | - | |
| 35Weak | Iterum Therapeutics plc | $41k 20,000 shares | +34% | - |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | ITRM Iterum Therapeutics plc | POpen-market purchase Ordinary Shares | +6,000 | $0.37 | $2,191 | 241,001 | Nov 20, 2025 |
| Aug 8, 2025 | ITRM Iterum Therapeutics plc | POpen-market purchase Ordinary Shares | +15,000 | $0.72 | $11k | 235,001 | Aug 12, 2025 |
| Dec 22, 2023 | ITRM Iterum Therapeutics plc | POpen-market purchase Ordinary Shares | +25,000 | $1.40 | $35k | 113,754 | Dec 27, 2023 |
| Dec 18, 2023 | ITRM Iterum Therapeutics plc | POpen-market purchase Ordinary Shares | +10,000 | $1.84 | $18k | 88,754 | Dec 19, 2023 |
| Nov 22, 2023 | ITRM Iterum Therapeutics plc | POpen-market purchase Ordinary Shares | +20,000 | $2.03 | $41k | 78,754 | Nov 27, 2023 |
Questions about Michael W. Dunne
Answered from the filings on this page, as of the latest one.
Is Michael W. Dunne buying or selling?
In the last 12 months Michael W. Dunne reported 1 open-market buy worth $2,191 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $2,191 of ITRM on Nov 18, 2025. Grants, option exercises and tax withholding are not counted.
How did Michael W. Dunne's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael W. Dunne has 0.
Where does Michael W. Dunne file Form 4?
Michael W. Dunne has filed Form 4 at ITRM (Iterum Therapeutics plc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.